Multilevel modulation of the mevalonate and protein-prenylation circuitries as a novel strategy for anticancer therapy
- 31 January 2007
- journal article
- Published by Elsevier in Trends in Pharmacological Sciences
- Vol. 28 (1) , 6-13
- https://doi.org/10.1016/j.tips.2006.11.005
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- A Novel Protein Geranylgeranyltransferase-I Inhibitor with High Potency, Selectivity, and Cellular ActivityJournal of Biological Chemistry, 2006
- The Role of Statins in Cancer TherapyThe Oncologist, 2006
- Development of Farnesyl Transferase Inhibitors: A ReviewThe Oncologist, 2005
- Post-prenylation-processing enzymes as new targets in oncogenesisNature Reviews Cancer, 2005
- Studies of the Isoprenoid-Mediated Inhibition of Mevalonate Synthesis Applied to Cancer Chemotherapy and ChemopreventionExperimental Biology and Medicine, 2004
- Isoprenoid biosynthesis in hereditary periodic fever syndromes and inflammationCellular and Molecular Life Sciences, 2003
- Lamins: building blocks or regulators of gene expression?Nature Reviews Molecular Cell Biology, 2002
- RHO–GTPases and cancerNature Reviews Cancer, 2002
- CaaX converting enzymesCurrent Opinion in Lipidology, 1998
- PROTEIN PRENYLATION: Molecular Mechanisms and Functional ConsequencesAnnual Review of Biochemistry, 1996